Navigation Links
Soluble IL-4 Receptor - A new boon for asthmatics

Bronchial asthma, the disease which is never an easy combat for any practising physician, is now being avenged by a new drug. A soluble interleukin-4 receptor (IL-4R), which acts as an IL-4 antagonist, appears to be safe and effective in preventing a decline in lung function and in preventing asthma symptoms.

In their study, Dr. Larry C. Borish, from the University of Virginia Health Sciences Center in Charlottesville, and colleagues randomly selected 62 patients with symptoms pertaining to moderate persistent asthma. They were stopped from inhaling corticosteroids and were divided into two groups. In one group IL-4 receptor were given and to the other group placebo was given.

It was found that, after a 12-week trial, those in the IL-4R group,there was no decline in FEV1; however, lung function did decline among those receiving placebo.

This study is "the demonstrate the potential clinical efficacy of a TH2 inhibitor for the treatment of asthma," the investigators note.

This soluble IL-4 receptor, which isn't a corticosteroid, selectivelyinhibits allergic mechanisms will be a new boon in the treatment strategy of asthma.

"These data demonstrate the critical role of IL-4 in the pathogenesis of asthma and the potential benefit of this approach to therapy," Dr. Borish and colleagues conclude.

Page: 1

Related medicine news :

1. Soluble Ingredient Can Make Fatty Fast Foods Healthier
2. Toll-like Receptor (Tlr3) Attachment Leads To Lethal Encephalitis
3. Genetic Variation In Bitter-Taste Receptor Gene Increases Alcoholic Risk
4. Calcium Receptor Vital For Stem Cell Migration to Bone Marrow
5. Researchers Identify Lung Failure Therapy Receptor
6. Effects Of Certain Food Related To Single Pain Receptors
7. Receptor for H.pylori Identified in Stomach
8. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
9. Schizophrenia Complicates With Altered Receptor Activity
10. Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging
11. Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer
Post Your Comments:

(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... June 23, 2016 The vast majority of ... dialysis facility.  Treatments are usually 3 times a week, ... visit, including travel time, equipment preparation and wait time. ... especially grueling for patients who are elderly and frail.  ... nursing and rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
Breaking Medicine Technology: